Pfizer Inc
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Total Biopharma Alliance Revenues by Quarter
Total Biopharma Alliance Revenues (cross-portfolio summary) — Worldwide revenues ($M) ($M)
Pfizer Total Biopharma Alliance Revenues: $2,697M in Q2 2026, up 18.7% from a year earlier. That is the highest of the 39 quarters on record here.
Where the Q2 2026 figure comes from
“|| Total Alliance revenues included above | $ | 2,697 | $ | 2,273 | 19% | 18% | $ | 2,174 | $ | 1,837 | 18% | $ | 523 | $ | 437 | 20% | 15%”
Source: Form 8-K (Earnings / Guidance Release) (pfe-6282026xex99.htm, filed 2026-08-04) ↗
Reported in Form 8-K Revenue Tables & Form 10-Q / 10-K Segment Footnotes.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up total Biopharma Alliance Revenues
- Total Biopharma Alliance Revenues (cross-portfolio summary) — U.S. revenues ($M)2,174 · Q2 2026
- Total Biopharma Alliance Revenues (cross-portfolio summary) — International revenues ($M)523 · Q2 2026
- Total Biopharma Alliance Revenues (cross-portfolio summary) — Worldwide reported YoY (%)19.0% · Q2 2026
- Total Biopharma Alliance Revenues (cross-portfolio summary) — Worldwide operational (constant-currency) YoY (%)18.0% · Q2 2026
Cite this data
StockData. (2026). Pfizer Total Biopharma Alliance Revenues ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/alliance-rev-ww
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.